Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Multiple Sclerosis

  Free Subscription


12.03.2018

1 Acta Neurol Scand
2 Ann Neurol
3 Brain
1 Can J Neurol Sci
1 J Neuroimmunol
2 J Neurol
1 Lancet Neurol
5 Mult Scler
2 Nat Rev Neurol
1 Nervenarzt
1 Neurol Clin Pract
2 Neurology
1 Neurosci Lett
1 PLoS One
2 Rev Neurol
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. RAHMANZADEH R, Weber MS, Bruck W, Navardi S, et al
    B cells in multiple sclerosis therapy-A comprehensive review.
    Acta Neurol Scand. 2018 Mar 7. doi: 10.1111/ane.12915.
    PubMed     Text format     Abstract available


    Ann Neurol

  2. COLES A
    Authorship of phase 3 trials in multiple sclerosis.
    Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25203.
    PubMed     Text format    

  3. MAGLIOZZI R, Howell OW, Nicholas R, Cruciani C, et al
    Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.
    Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25197.
    PubMed     Text format     Abstract available


    Brain

  4. STEYERBERG EW, Claggett B
    Towards personalized therapy for multiple sclerosis: limitations of observational data.
    Brain. 2018 Mar 3. pii: 4919652. doi: 10.1093.
    PubMed     Text format    

  5. STEPHENSON EL, Mishra MK, Moussienko D, Laflamme N, et al
    Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.
    Brain. 2018 Mar 1. pii: 4915907. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. KALINCIK T
    Reply: Towards personalized therapy for multiple sclerosis: limitations of observational data.
    Brain. 2018 Mar 3. pii: 4919653. doi: 10.1093.
    PubMed     Text format    


    Can J Neurol Sci

  7. SADOVNICK AD, Yee IM, Attwell-Pope K, Keyes G, et al
    Patient-Reported Benefits of Extracranial Venous Therapy: British Columbia CCSVI Registry.
    Can J Neurol Sci. 2017;44:246-254.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  8. MONTEIRO A, Cruto C, Rosado P, Martinho A, et al
    Characterization of circulating gamma-delta T cells in relapsing vs remission multiple sclerosis.
    J Neuroimmunol. 2018 Feb 24. pii: S0165-5728(17)30533.
    PubMed     Text format     Abstract available


    J Neurol

  9. LOREFICE L, Fenu G, Pitzalis R, Scalas G, et al
    Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study.
    J Neurol. 2018 Mar 5. pii: 10.1007/s00415-018-8811.
    PubMed     Text format     Abstract available

  10. HOTTENROTT T, Schorb E, Fritsch K, Dersch R, et al
    The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.
    J Neurol. 2018 Mar 6. pii: 10.1007/s00415-018-8779.
    PubMed     Text format     Abstract available


    Lancet Neurol

  11. CAPRARIELLO AV, Stys PK
    Two steps forward for myelin repair in multiple sclerosis.
    Lancet Neurol. 2018 Feb 26. pii: S1474-4422(18)30070.
    PubMed     Text format    


    Mult Scler

  12. LEE JY, De Jager PL
    What is the epigenome and is it involved in multiple sclerosis?
    Mult Scler. 2018;24:268-269.
    PubMed     Text format    

  13. BROWNLEE WJ, Altmann DR, Alves Da Mota P, Swanton JK, et al
    Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.
    Mult Scler. 2017;23:665-674.
    PubMed     Text format     Abstract available

  14. GOBEL K, Ruck T, Meuth SG
    Cytokine signaling in multiple sclerosis: Lost in translation.
    Mult Scler. 2018 Mar 1:1352458518763094. doi: 10.1177/1352458518763094.
    PubMed     Text format     Abstract available

  15. SORMANI MP, Kappos L, Radue EW, Cohen J, et al
    Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
    Mult Scler. 2017;23:656-664.
    PubMed     Text format     Abstract available

  16. KOENIG KA, Rao SM, Lowe MJ, Lin J, et al
    The role of the thalamus and hippocampus in episodic memory performance in patients with multiple sclerosis.
    Mult Scler. 2018 Mar 1:1352458518760716. doi: 10.1177/1352458518760716.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  17. GERALDES R, Ciccarelli O, Barkhof F, De Stefano N, et al
    The current role of MRI in differentiating multiple sclerosis from its imaging mimics.
    Nat Rev Neurol. 2018 Mar 9. pii: nrneurol.2018.14. doi: 10.1038/nrneurol.2018.
    PubMed     Text format     Abstract available

  18. FYFE I
    Multiple sclerosis: CSF markers predict progression from radiologically isolated syndrome.
    Nat Rev Neurol. 2018 Mar 2. pii: nrneurol.2018.26. doi: 10.1038/nrneurol.2018.
    PubMed     Text format    


    Nervenarzt

  19. HAGHIKIA A, Linker RA
    [Nutrition, microbiome and multiple sclerosis : Current knowledge from basic research and clinical practice].
    Nervenarzt. 2018 Mar 7. pii: 10.1007/s00115-018-0497.
    PubMed     Text format     Abstract available


    Neurol Clin Pract

  20. MARRIE RA, Leung S, Yu N, Elliott L, et al
    Lower prevalence of multiple sclerosis in First Nations Canadians.
    Neurol Clin Pract. 2018;8:33-39.
    PubMed     Text format     Abstract available


    Neurology

  21. TREMLETT H, Zhu F, Ascherio A, Munger KL, et al
    Sun exposure over the life course and associations with multiple sclerosis.
    Neurology. 2018 Mar 7. pii: WNL.0000000000005257.
    PubMed     Text format     Abstract available

  22. MILLER AE, Calabresi PA
    Central vein sign in multiple sclerosis: Ready for front and center?
    Neurology. 2018 Mar 7. pii: WNL.0000000000005241.
    PubMed     Text format    


    Neurosci Lett

  23. ZHANG ML, Zhang XJ, Kang J, Zhang HJ, et al
    Matrine promotes NT3 expression in CNS cells in experimental autoimmune encephalomyelitis.
    Neurosci Lett. 2017;649:100-106.
    PubMed     Text format     Abstract available


    PLoS One

  24. KHAN A, Kamran S, Ponirakis G, Akhtar N, et al
    Peripheral neuropathy in patients with multiple sclerosis.
    PLoS One. 2018;13:e0193270.
    PubMed     Text format     Abstract available


    Rev Neurol

  25. FERNANDEZ JIMENEZ-ORTIZ H, Reche-Sainz JA, Villarrubia-Torcal B, Toledano-Fernandez N, et al
    [Appraisal of the formation of afterimages by means of a new computer application in patients with demyelinating optic neuropathies].
    Rev Neurol. 2016;63:337-344.
    PubMed     Text format     Abstract available

  26. LOPEZ-MARTIN D, Martinez-Anton J
    [Optic neuritis in childhood. A pediatric series, literature review and treatment approach].
    Rev Neurol. 2016;63:103-8.
    PubMed     Text format     Abstract available


    Rev Neurol (Paris)

  27. VAN OBBERGHEN EK, Cohen M, Rocher F, Lebrun-Frenay C, et al
    Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS?
    Rev Neurol (Paris). 2017;173:222-224.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: